RGPX
Regenerex Pharma, Inc.Company with tickers: RGPX
CIK
1357878
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $512,664 | USD | 2024-09-30 | 10-Q | 2025-11-17 |
| Research & Development | $133,506 | USD | 2025-09-30 | 10-Q | 2025-11-17 |
| Operating Income | $-512,664 | USD | 2024-09-30 | 10-Q | 2025-11-17 |
| Net Income | $-272,560 | USD | 2024-06-30 | 10-Q | 2025-11-17 |
| EPS (Basic) | — | ||||
| EPS (Diluted) | — |